Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs

• Päätekijät: Yuki Ito (Tekijä), Konan Hara (Tekijä), Byung-Kwang Yoo (Tekijä), Jun Tomio (Tekijä), Yasuki Kobayashi (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2019-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Higher income population tend to prefer brand-name to generic drugs, which may cause disparity in access to brand-name drugs among income groups. A potential policy that can resolve such disparity is imposing a greater co-payment rate on high-income enrollees. However, the effect...